Pfizer的股票在报告“Q4”收入和收入比分析师的估计数要少之后上升。 Pfizer's stock rose after reporting Q4 earnings and revenue that beat analysts' estimates.

Pfizer的股票在星期一上涨了1.2%至22.18美元,因为生物制药公司报告说,Q4的收益为每股0.63美元,击败分析师的估计数为15美元,收入为177.6亿美元,超过预期5亿美元。 Pfizer's stock rose 1.2% to $22.18 on Monday, after the biopharmaceutical company reported Q4 earnings of $0.63 per share, beating analyst estimates by $0.15, and revenue of $17.76 billion, surpassing expectations by $500 million. 股价为31.07美元的价格目标。 The stock has a "Moderate Buy" rating and a $31.07 price target. 机构投资者对该公司的股份一直在增加,Belpointe资产管理公司和Savvy顾问公司在第四季度都增加了股份。 Institutional investors have been increasing their stakes in the company, with Belpointe Asset Management and Savvy Advisors Inc. both adding shares in the fourth quarter.